| scholarly article | Q13442814 |
| P50 | author | Pierre Busson | Q61149505 |
| P2093 | author name string | T Tursz | |
| N Raab-Traub | |||
| R McCoy | |||
| K Gilligan | |||
| R Sadler | |||
| P2860 | cites work | Complementary DNA sequence of a human cytoplasmic actin. Interspecies divergence of 3' non-coding regions | Q28274784 |
| Identification of Epstein-Barr virus terminal protein 1 (TP1) in extracts of four lymphoid cell lines, expression in insect cells, and detection of antibodies in human sera | Q33905718 | ||
| Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma | Q33937673 | ||
| DNA of Epstein-Barr virus detected in tissue of Burkitt's lymphoma and nasopharyngeal carcinoma | Q34743617 | ||
| Differential expression of Epstein Barr viral transcripts for two proteins (TP1 and LMP) in lymphocyte and epithelial cells | Q35805021 | ||
| A spliced Epstein-Barr virus gene expressed in immortalized lymphocytes is created by circularization of the linear viral genome | Q36344649 | ||
| An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase | Q36701288 | ||
| Two related Epstein-Barr virus membrane proteins are encoded by separate genes | Q36780955 | ||
| A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. | Q36806077 | ||
| Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein expressed in vivo | Q36822172 | ||
| Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells | Q37521760 | ||
| Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene | Q40062679 | ||
| The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA | Q40067397 | ||
| Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: Correlated nucleic acid hybridization and histopathological examination | Q40106496 | ||
| The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation | Q43610021 | ||
| The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. | Q45835618 | ||
| Expression of Epstein-Barr virus-encoded proteins in nasopharyngeal carcinoma. | Q45841044 | ||
| Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas | Q70061763 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 3257-3262 | |
| P577 | publication date | 1992-05-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma | |
| P478 | volume | 66 |
| Q35852557 | 5' Coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio |
| Q24529019 | An Epstein-Barr virus protein interacts with Notch |
| Q38249887 | Cancer stem-like cells in Epstein-Barr virus-associated nasopharyngeal carcinoma |
| Q34502958 | Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line |
| Q98288416 | Co-presence of human papillomaviruses and Epstein-Barr virus is linked with advanced tumor stage: a tissue microarray study in head and neck cancer patients |
| Q35463816 | Comparison of humoral immune responses to Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus using a viral proteome microarray |
| Q24800020 | Cytokine and immunoglobulin production by PWM-stimulated peripheral and tumor-infiltrating lymphocytes of undifferentiated nasopharyngeal carcinoma (NPC) patients |
| Q36651589 | Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B. |
| Q40684609 | Detection and characterization of Epstein-Barr virus in clinical specimens. |
| Q33813796 | Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal Src kinase. |
| Q36653989 | Epstein-Barr virus (EBV) gene expression in EBV-positive peripheral T-cell lymphomas. |
| Q36898733 | Epstein-Barr virus BART microRNAs are produced from a large intron prior to splicing |
| Q35875444 | Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation |
| Q39585482 | Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. |
| Q24524255 | Epstein-Barr virus LMP2A-induced B-cell survival in two unique classes of EmuLMP2A transgenic mice |
| Q38322174 | Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells |
| Q56947843 | Epstein-Barr virus and nasopharyngeal carcinoma |
| Q36637195 | Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. |
| Q35873657 | Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. |
| Q37336691 | Epstein-Barr virus latent membrane protein 2 effects on epithelial acinus development reveal distinct requirements for the PY and YEEA motifs |
| Q38886673 | Epstein-Barr virus latent membrane protein 2 induces autophagy to promote abnormal acinus formation |
| Q36890676 | Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells. |
| Q36646940 | Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes |
| Q39148562 | Epstein-Barr virus latent membrane protein 2A contributes to anoikis resistance through ERK activation |
| Q36086653 | Epstein-Barr virus latent membrane protein 2A promotes invasion of nasopharyngeal carcinoma cells through ERK/Fra-1-mediated induction of matrix metalloproteinase 9 |
| Q34344427 | Epstein-Barr virus latent membrane protein 2A regulates c-Jun protein through extracellular signal-regulated kinase |
| Q36276627 | Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through αv-integrin membrane translocation |
| Q34029669 | Epstein-Barr virus latent membrane protein-2A-induced DeltaNp63alpha expression is associated with impaired epithelial-cell differentiation |
| Q33598586 | Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma |
| Q38968588 | Epstein-Barr virus: more than 50 years old and still providing surprises. |
| Q34228703 | Epstein-Barr-virus-encoded LMP2A induces primary epithelial cell migration and invasion: possible role in nasopharyngeal carcinoma metastasis |
| Q33784983 | Establishment and characterization of a human Epstein-Barr virus-associated gastric carcinoma in SCID mice |
| Q30452144 | HLA A2.1-restricted cytotoxic T cells recognizing a range of Epstein-Barr virus isolates through a defined epitope in latent membrane protein LMP2 |
| Q38302963 | Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes. |
| Q40275967 | Identification of Epstein-Barr virus RK-BARF0-interacting proteins and characterization of expression pattern. |
| Q36849568 | Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus |
| Q55313422 | Interplay of Viral Infection, Host Cell Factors and Tumor Microenvironment in the Pathogenesis of Nasopharyngeal Carcinoma. |
| Q35865472 | Isolation of intertypic recombinants of Epstein-Barr virus from T-cell-immunocompromised individuals |
| Q36628637 | Major histocompatibility complex-restricted CD8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize Env and Gag/PR proteins. |
| Q37399274 | Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22 |
| Q36655549 | Mutants of Epstein-Barr virus with a selective marker disrupting the TP gene transform B cells and replicate normally in culture |
| Q39875574 | Peptide transporter (TAP-1 and TAP-2)-independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A: implications for cytotoxic T-lymphocyte control of EBV-associated malignancies. |
| Q36944141 | Potential selection of LMP1 variants in nasopharyngeal carcinoma |
| Q33781678 | Roles of the ITAM and PY motifs of Epstein-Barr virus latent membrane protein 2A in the inhibition of epithelial cell differentiation and activation of {beta}-catenin signaling |
| Q38926327 | SYK interaction with ITGβ4 suppressed by Epstein-Barr virus LMP2A modulates migration and invasion of nasopharyngeal carcinoma cells |
| Q35832657 | Structural analyses of the Epstein-Barr virus BamHI A transcripts |
| Q39805000 | Synergism of BARF1 with Ras induces malignant transformation in primary primate epithelial cells and human nasopharyngeal epithelial cells |
| Q36687455 | The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle |
| Q35842451 | The Epstein-Barr virus 3.5-kilobase latent membrane protein 1 mRNA initiates from a TATA-Less promoter within the first terminal repeat |
| Q35841701 | The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. |
| Q33783746 | The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive |
| Q40471301 | The Epstein-Barr virus-encoded LMP2A and LMP2B proteins promote epithelial cell spreading and motility. |
| Q42790345 | The expression of variant CD44 in nasopharyngeal carcinoma is unrelated to expression of LMP-1 |
| Q36686042 | The last seven transmembrane and carboxy-terminal cytoplasmic domains of Epstein-Barr virus latent membrane protein 2 (LMP2) are dispensable for lymphocyte infection and growth transformation in vitro. |
| Q36685081 | The only domain which distinguishes Epstein-Barr virus latent membrane protein 2A (LMP2A) from LMP2B is dispensable for lymphocyte infection and growth transformation in vitro; LMP2A is therefore nonessential |
| Q64946489 | The regulatory network of nasopharyngeal carcinoma metastasis with a focus on EBV, lncRNAs and miRNAs. |
| Q35924359 | The role of miRNAs and EBV BARTs in NPC. |
| Q36135900 | Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells |
| Q40045221 | Transcripts from the Epstein-Barr virus BamHI A fragment are detectable in all three forms of virus latency. |
| Q26823898 | Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients |
| Q35798133 | Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia |
Search more.